Eyal Schwartzberg

Eyal Schwartzberg is a seasoned professional with extensive experience in healthcare management and academia. Currently serving as Founder and Chairman at ApoWiser Ltd. since January 2021, Schwartzberg also holds roles as a Management Consultant and General Manager at Neopharm Group since March 2019, and as an adjunct associate professor at Long Island University. Schwartzberg has been an Associate Professor at Ben-Gurion University of the Negev since 2004, where leadership of the Master's Program in Community Clinical Pharmacy and Regulatory Management is a key responsibility. Previous positions include Deputy Director General for Research, Development & Innovation at Tel Aviv Medical Center and Head of the Pharmaceutical & Enforcement Divisions at the Israel Ministry of Health. Educational credentials include a PhD in Health System Management from Ben-Gurion University, an MSc in Evidence Based Pharmacotherapy from Aston University, and a BPharm in Pharmacy from Cardiff University.